KATHRYN E FALBERG
CIK 1206977 · EVP and CFO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.98M
Companies
15
Total Filings
126
Lifetime Open-Market Net
-$70.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCUS | Director | 176,406 | $26.45 | $4.67M | $1.55M | 13 | 2026-06-12 |
| NUVB | Director | — | $6.59 | — | $0 | 1 | 2026-05-26 |
| TTD | Director | 212 | $19.09 | $4.0K | -$73.56M | 24 | 2026-03-25 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 75,041 | $0.01 | $383 | $483.8K | 8 | 2025-05-23 |
| Tricida, Inc. (TCDA) Delisted | Director | 59,163 | $0.11 | $6.4K | $600.0K | 5 | 2022-06-16 |
| URGN | Director | — | $40.45 | — | $0 | 3 | 2021-06-09 |
| COLL | Director | 0 | $36.29 | $0 | $960.0K | 7 | 2020-10-14 |
| BMRN | Director | 2,640 | $61.37 | $162.0K | $0 | 2 | 2016-09-01 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 82,742 | — | — | $2.94M | 7 | 2016-06-23 |
| LIFE | Director | — | $19.84 | — | $0 | 3 | 2016-05-26 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 358,253 | — | — | $942.1K | 12 | 2016-05-06 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | Director | 94,894 | — | — | $400.0K | 1 | 2015-08-11 |
| JAZZ | EVP and CFO | 133,387 | $255.97 | $34.14M | -$4.52M | 27 | 2014-03-06 |
| QLTI | Director | — | $26.90 | — | $0 | 3 | 2011-05-27 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | CFO and COO | 1 | $28.80 | $29 | -$75.9K | 3 | 2009-06-26 |
Recent Filings · Page 11 of 13
126 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-08-17 | JAZZ | Sell (S) | −60,000 | -$2.85M | EDGAR |
| 2012-08-13 | JAZZ | Grant (A) | +35,000 | $0 | EDGAR |
| 2012-06-04 | JAZZ | Other (J) | +2,581 | $16.6K | EDGAR |
| 2012-05-04 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2012-01-18 | JAZZ | Grant (A) | +111,201 | $0 | EDGAR |
| 2012-01-18 | JAZZ | Disp (D) | −111,201 | $0 | EDGAR |
| 2012-01-13 | JAZZ | Mixed | +54,773 | -$2.15M | EDGAR |
| 2011-12-02 | JAZZ | Other (J) | +2,363 | $15.2K | EDGAR |
| 2011-11-14 | JAZZ | Buy (P) | +3,000 | $112.1K | EDGAR |
| 2011-06-02 | JAZZ | Other (J) | +479 | $3.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.